Senex Biotechnology

Developing cancer therapeutics, targeting drug resistance and metastasis for incurable cancers

placeColumbia, South Carolina, United States calendar_todayFounded 2002 groups6 employees language senexbio.com

Registered entities

Innovation

24 patent families (8 granted) — focus: Human necessities, Chemistry & metallurgy, Physics & computing; filing pace slowing. Cited 497 times.

YearFilings
20144
20152
20164
20172
20181
20191
20205
20215
20223
20233
20243
20255

Investor mix

3 investors on record.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon